Bellevue Healthcare (BBH) Competitors GBX 126.56 -1.44 (-1.12%) As of 03/25/2025 12:42 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BBH vs. TFG, LWDB, JMG, ASL, IHP, EDIN, FSV, ASHM, GSS, and BPCRShould you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Tetragon Financial (TFG), Law Debenture (LWDB), JPMorgan Emerging Markets (JMG), Aberforth Smaller Companies Trust (ASL), IntegraFin (IHP), Edinburgh Investment (EDIN), Fidelity Investment Trust - Fidelity Special Values (FSV), Ashmore Group (ASHM), Genesis Emerging Markets Fund (GSS), and BioPharma Credit (BPCR). These companies are all part of the "asset management" industry. Bellevue Healthcare vs. Tetragon Financial Law Debenture JPMorgan Emerging Markets Aberforth Smaller Companies Trust IntegraFin Edinburgh Investment Fidelity Investment Trust - Fidelity Special Values Ashmore Group Genesis Emerging Markets Fund BioPharma Credit Tetragon Financial (LON:TFG) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation. Does the MarketBeat Community believe in TFG or BBH? Bellevue Healthcare received 87 more outperform votes than Tetragon Financial when rated by MarketBeat users. However, 77.42% of users gave Tetragon Financial an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote. CompanyUnderperformOutperformTetragon FinancialOutperform Votes2477.42% Underperform Votes722.58% Bellevue HealthcareOutperform Votes11168.52% Underperform Votes5131.48% Is TFG or BBH a better dividend stock? Tetragon Financial pays an annual dividend of GBX 44 per share and has a dividend yield of 297.1%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.7%. Tetragon Financial pays out 2,822.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Do institutionals and insiders have more ownership in TFG or BBH? 3.2% of Tetragon Financial shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 17.8% of Tetragon Financial shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is TFG or BBH more profitable? Bellevue Healthcare has a net margin of 169.10% compared to Tetragon Financial's net margin of 57.23%. Tetragon Financial's return on equity of 4.68% beat Bellevue Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Tetragon Financial57.23% 4.68% 3.14% Bellevue Healthcare 169.10%-4.48%N/A Which has better earnings and valuation, TFG or BBH? Tetragon Financial has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Tetragon Financial, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTetragon Financial£22.12B0.05£12.66B£1.569.50Bellevue Healthcare-£9.60M-32.51-£16.23M-£6.57-19.25 Does the media favor TFG or BBH? In the previous week, Bellevue Healthcare had 1 more articles in the media than Tetragon Financial. MarketBeat recorded 2 mentions for Bellevue Healthcare and 1 mentions for Tetragon Financial. Tetragon Financial's average media sentiment score of 0.67 beat Bellevue Healthcare's score of 0.62 indicating that Tetragon Financial is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tetragon Financial 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bellevue Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTetragon Financial beats Bellevue Healthcare on 11 of the 16 factors compared between the two stocks. Remove Ads Get Bellevue Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBH vs. The Competition Export to ExcelMetricBellevue HealthcareAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£311.93M£1.17B£4.28B£2.61BDividend Yield3.82%4.41%4.18%4.95%P/E Ratio-19.2527.0916.01152.77Price / Sales-32.512,289.551,718.75283,340.74Price / CashN/A60.8148.9727.97Price / Book0.841.123.374.61Net Income-£16.23M£258.33M£1.27B£5.78B7 Day Performance-0.34%0.17%0.54%-0.25%1 Month Performance-8.42%-1.64%6.75%4.02%1 Year Performance-16.07%5.38%11.03%126.57% Bellevue Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBHBellevue HealthcareN/AGBX 126.57-1.1%N/A-15.4%£311.93M£-9,595,061.74-19.25N/AHigh Trading VolumeTFGTetragon FinancialN/AGBX 14.96-0.3%N/A+51.9%£1.21B£22.12B9.60N/ALWDBLaw DebentureN/AGBX 910.88+0.9%N/A+14.2%£1.20B£203.87M8.48260News CoveragePositive NewsJMGJPMorgan Emerging MarketsN/AGBX 107.80-0.2%N/A+2.9%£1.14B£97.45M14.28N/AHigh Trading VolumeASLAberforth Smaller Companies TrustN/AGBX 1,366+0.1%N/A+0.3%£1.14B£226.05M4.49N/APositive NewsHigh Trading VolumeIHPIntegraFin3.3375 of 5 starsGBX 334flatGBX 413.33+23.8%+19.7%£1.11B£138.65M21.183,520Dividend IncreaseNews CoverageHigh Trading VolumeEDINEdinburgh InvestmentN/AGBX 750.38+0.2%N/A+8.7%£1.09B£189.32M6.00N/ADividend IncreaseFSVFidelity Investment Trust - Fidelity Special ValuesN/AGBX 332.11+0.2%N/A+15.6%£1.08B£237.18M4.8325,000Positive NewsASHMAshmore Group1.504 of 5 starsGBX 158.60-1.2%GBX 174+9.7%-21.2%£1.06B£199.65M11.24283High Trading VolumeGSSGenesis Emerging Markets FundN/AN/AN/AN/A£1.06B£250.40M6.181,626Gap DownBPCRBioPharma CreditN/AGBX 0.89-0.2%N/A-2.2%£1.05B£12.99B10.09N/APositive News Remove Ads Related Companies and Tools Related Companies Tetragon Financial Alternatives Law Debenture Alternatives JPMorgan Emerging Markets Alternatives Aberforth Smaller Companies Trust Alternatives IntegraFin Alternatives Edinburgh Investment Alternatives Fidelity Investment Trust - Fidelity Special Values Alternatives Ashmore Group Alternatives Genesis Emerging Markets Fund Alternatives BioPharma Credit Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BBH) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Healthcare Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.